Dr. Eaton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Lunder Building LL2
Boston, MA 02114Phone+1 404-644-6268
Education & Training
- Emory University School of MedicineResidency, Radiation Oncology, 2010 - 2014
- Emory University School of MedicineInternship, Internal Medicine, 2009 - 2010
- Medical University of South CarolinaClass of 2009
Certifications & Licensure
- GA State Medical License 2015 - 2024
- NC State Medical License 2020 - 2022
- AL State Medical License 2020 - 2020
- MA State Medical License 2014 - 2015
- American Board of Radiology Radiation Oncology
Clinical Trials
- Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study Start of enrollment: 2020 Feb 18
- Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors Start of enrollment: 2018 Dec 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 9 citationsOnboard cone-beam CT-based replan evaluation for head and neck proton therapy.Alexander Stanforth, Liyong Lin, Jonathan J Beitler, James R Janopaul-Naylor, Chih-Wei Chang
Journal of Applied Clinical Medical Physics. 2022-05-01 - 3 citationsRadiation for pediatric low-grade gliomas: who will benefit and how late is soon enough?Bree R. Eaton, Torunn I. Yock
Neuro-Oncology. 2020-08-17 - 17 citationsEwing sarcoma.Bree R Eaton, Line Claude, Daniel J Indelicato, Ralph Vatner, Brian Yeh
Pediatric Blood & Cancer. 2021-05-01
Journal Articles
- Fractionated Radiotherapy Is Associated with Lower Rates of Treatment-Related Edema Than Stereotactic Radiosurgery in MRI-Defined MeningiomasBree R Eaton, Ian R Crocker, Arif N Ali, Hui-Kuo G Shu, World Neurosurgery
Authored Content
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: